Thrombate III is the only antithrombin concentrate approved in both adult and pediatric patients for hereditary antithrombin deficiency. The Food and Drug Administration (FDA) has expanded the ...

Antithrombin, a plasma protein, has been reported to control thrombin activity by directly binding to thrombin, as well as to have an anti-inflammatory effect. However, the actual molecular mechanism ...

BOSTON, Mass., July 16, 2009– Data presented at the annual meeting of the International Society on Thrombosis and Haemostasis (ISTH) in Boston show that ATryn® (Antithrombin [Recombinant]) safely ...

When to treat patients with heparin and when to treat using an antithrombin concentrate; Why it is important to aggressively treat patients with type one antithrombin deficiency who have already ...

In June 2021, Kenneth A. Bauer, MD, from Beth Israel Deaconess Medical Center and professor of medicine at Harvard Medical School, spoke with Healio about the diagnosis and treatment of hereditary ...

BACKGROUND Acquired Antithrombin (AT) deficiency is a common and prognostically important finding in sick preterm infants with respiratory distress syndrome (RDS). It has been hypothesised that AT ...

The differential diagnosis of VTE includes other inherited thrombophilias and acquired thrombophilia. Individuals with other inherited thrombophilias will have laboratory evidence of a specific defect ...

The authors review 8 cases of thrombosis in uncommon sites caused by protein S deficiency. Hypercoagulability, venous stasis, and vessel wall injury predispose to thrombus formation. Thrombophilia can ...